Submitted:
08 November 2023
Posted:
09 November 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Collection of samples
2.2. Isolation and identification of K. pneumoniae
2.3. Identification of K. pneumoniae by PCR and partial sequencing of 16S rDNA
2.4. Antimicrobial susceptibility profile
2.4.1. Selected Antibiotics Discs
2.4.2. Antibiogram Assay
3. Results
| Type of Samples | Total Number of Samples | Number of Positive Samples |
|---|---|---|
| Raw cow’s milk | 46 | 3 (6.5%) |
| Raw she camel’s milk | 5 | 1(20%) |
| Raw fermented milk | 28 | 1(3.5%) |
| UHT milk | 8 | 0 |
| Yoghurt | 5 | 0 |
| Maasora cheese | 21 | 4(19%) |
| Ricotta cheese | 13 | 1(7.6%) |
| Imported soft cheese | 6 | 1 (16.6%) |
| Ice cream | 6 | 0 |
| Full cream milk powder | 10 | 2(20 %) |
| Skimmed milk powder | 6 | 0 |
| Powder infant formula | 36 | 1 (2.7 %) |
| Growing up formula | 18 | 1 (5.5 %) |
| Ready to feed baby milk | 10 | 0 |
| Cereal baby food | 16 | 1(6.25%) |
| Total | 234 | 16 (6.8%) |
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Chaudhry, T.H.; Aslam, B.; Arshad, M.I.; Alvi, R.F.; Muzammil, S.; Yasmeen, N.; Aslam, M.A.; Khurshid, M.; Rasool, M.H.; Baloch, Z. Emergence of blaNDM-1 Harboring Klebsiella pneumoniae ST29 and ST11 in Veterinary Settings and Waste of Pakistan. Infection and Drug Resistance 2020, 13, 3033. [Google Scholar] [CrossRef]
- Martin, R.M.; Bachman, M.A. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Frontiers in cellular and infection microbiology 2018, 8, 4. [Google Scholar] [CrossRef] [PubMed]
- Guo, X.; Cao, Z.; Dai, Z.; Li, Y.; He, X.; Hu, X.; Tian, F.; Ren, Y. Antimicrobial susceptibility and molecular epidemiology of multidrug-resistant Klebsiella pneumoniae in Central China. Japanese journal of infectious diseases 2017, 70, 229–234. [Google Scholar] [CrossRef] [PubMed]
- Mohamed, E.R.; Aly, S.A.; Halby, H.M.; Ahmed, S.H.; Zakaria, A.M.; El-Asheer, O.M. Epidemiological typing of multidrug-resistant Klebsiella pneumoniae, which causes paediatric ventilator-associated pneumonia in Egypt. Journal of medical microbiology 2017, 66, 628–634. [Google Scholar] [CrossRef] [PubMed]
- Munoz, M.A.; Welcome, F.L.; Schukken, Y.H.; Zadoks, R.N. Molecular epidemiology of two Klebsiella pneumoniae mastitis outbreaks on a dairy farm in New York State. Journal of clinical microbiology 2007, 45, 3964–3971. [Google Scholar] [CrossRef]
- Liang, L.; Wang, P.; Zhao, X.; He, L.; Qu, T.; Chen, Y. Single-molecule real-time sequencing reveals differences in bacterial diversity in raw milk in different regions and seasons in China. Journal of dairy science 2022, 105, 5669–5684. [Google Scholar] [CrossRef]
- Paulin-Curlee, G.; Singer, R.; Sreevatsan, S.; Isaacson, R.; Reneau, J.; Foster, D.; Bey, R. Genetic diversity of mastitis-associated Klebsiella pneumoniae in dairy cows. Journal of dairy science 2007, 90, 3681–3689. [Google Scholar] [CrossRef] [PubMed]
- Kanevsky-Mullarky, I.; Nedrow, A.; Garst, S.; Wark, W.; Dickenson, M.; Petersson-Wolfe, C.; Zadoks, R. Comparison of virulence factors in Klebsiella pneumoniae strains associated with multiple or single cases of mastitis. Journal of dairy science 2014, 97, 2213–2218. [Google Scholar] [CrossRef]
- Tartor, Y.H.; El-Aziz, A.; Norhan, K.; Gharieb, R.; El Damaty, H.M.; Enany, S.; Soliman, E.A.; Abdellatif, S.S.; Attia, A.S.; Bahnass, M.M. Whole-genome sequencing of gram-negative bacteria isolated from bovine mastitis and raw milk: the first emergence of colistin mcr-10 and fosfomycin fosA5 resistance genes in Klebsiella pneumoniae in middle east. Frontiers in microbiology 2021, 3596. [Google Scholar] [CrossRef]
- Wyres, K.L.; Wick, R.R.; Judd, L.M.; Froumine, R.; Tokolyi, A.; Gorrie, C.L.; Lam, M.M.; Duchêne, S.; Jenney, A.; Holt, K.E. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae. PLoS genetics 2019, 15, e1008114. [Google Scholar] [CrossRef]
- Bhagirath, A.Y.; Li, Y.; Patidar, R.; Yerex, K.; Ma, X.; Kumar, A.; Duan, K. Two component regulatory systems and antibiotic resistance in Gram-negative pathogens. International journal of molecular sciences 2019, 20, 1781. [Google Scholar] [CrossRef] [PubMed]
- Wu, X.; Liu, J.; Feng, J.; Shabbir, M.A.B.; Feng, Y.; Guo, R.; Zhou, M.; Hou, S.; Wang, G.; Hao, H. Epidemiology, Environmental Risks, Virulence, and Resistance Determinants of Klebsiella pneumoniae From Dairy Cows in Hubei, China. Frontiers in microbiology 2022, 13. [Google Scholar] [CrossRef] [PubMed]
- Montso, K.P.; Dlamini, S.B.; Kumar, A.; Ateba, C.N. Antimicrobial Resistance Factors of Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae Isolated from Cattle Farms and Raw Beef in North-West Province, South Africa. BioMed research international 2019, 2019. [Google Scholar] [CrossRef] [PubMed]
- Wareth, G.; Linde, J.; Hammer, P.; Pletz, M.W.; Neubauer, H.; Sprague, L.D. WGS-based phenotyping and molecular characterization of the resistome, virulome and plasmid replicons in Klebsiella pneumoniae Isolates from powdered milk produced in Germany. Microorganisms 2022, 10, 564. [Google Scholar] [CrossRef] [PubMed]
- Garbaj AM, Awad EM, Azwai SM, Abolghait SK, Naas HT, Moawad AA, Gammoudi FT, Barbieri I, Eldaghayes IM. Enterohemorrhagic Escherichia coli O157 in milk and dairy products from Libya: Isolation and molecular identification by partial sequencing of 16S rDNA. Vet World. 2016 Nov;9(11):1184-1189. [CrossRef]
- Garbaj AM, Gawella TBB, Sherif JA, Naas HT, Eshamah HL, Azwai SM, Gammoudi FT, Abolghait SK, Moawad AA, Barbieri I, Eldaghayes IM. Occurrence and antibiogram of multidrug-resistant Salmonella enterica isolated from dairy products in Libya. Vet World. 2022 May;15(5):1185-1190. [CrossRef]
- Garbaj AM, Abolghait SK, Lawila AF, Azwai SM, Naas HT, et al. (2017) Molecular Identification, Prevalence and Antimicrobial Susceptibility Profile of Cronobacter spp. Cultivated on a Chromogenic Medium in Libya. J Mol Microbiol. Vol. 1 No. 1: 8.
- Davis, G.S.; Waits, K.; Nordstrom, L.; Weaver, B.; Aziz, M.; Gauld, L.; Grande, H.; Bigler, R.; Horwinski, J.; Porter, S. Intermingled Klebsiella pneumoniae populations between retail meats and human urinary tract infections. Clinical Infectious Diseases 2015, 61, 892–899. [Google Scholar] [CrossRef] [PubMed]
- Azwai, S.; Alfallani, E.; Abolghait, S.; Garbaj, A.; Naas, H.; Moawad, A.; Gammoudi, F.; Rayes, H.; Barbieri, I.; Eldaghayes, I. Isolation and molecular identification of Vibrio spp. by sequencing of 16S rDNA from seafood, meat and meat products in Libya. Open Veterinary Journal 2016, 6, 36–43. [Google Scholar] [CrossRef]
- Pereira, S.; Vanetti, M. Potential virulence of Klebsiella sp. isolates from enteral diets. Brazilian Journal of Medical and Biological Research 2015, 48, 782–789. [Google Scholar] [CrossRef]
- Jana, B.; Cain, A.K.; Doerrler, W.T.; Boinett, C.J.; Fookes, M.C.; Parkhill, J.; Guardabassi, L. The secondary resistome of multidrug-resistant Klebsiella pneumoniae. Scientific reports 2017, 7, 42483. [Google Scholar] [CrossRef]
- Gaffer, W.; Gwida, M.; Samra, R.A.; Al-Ashmawy, M. Occurrence and molecular characterization of extended spectrum beta-lactamase producing Enterobacteriaceae in milk and some dairy products. Slovenian Veterinary Research 2019, 56. [Google Scholar] [CrossRef]
- Osman, K.M.; Hassan, H.M.; Orabi, A.; Abdelhafez, A.S. Phenotypic, antimicrobial susceptibility profile and virulence factors of Klebsiella pneumoniae isolated from buffalo and cow mastitic milk. Pathogens and global health 2014, 108, 191–199. [Google Scholar] [CrossRef]
- Garedew, L.; Berhanu, A.; Mengesha, D.; Tsegay, G. Identification of gram-negative bacteria from critical control points of raw and pasteurized cow milk consumed at Gondar town and its suburbs, Ethiopia. BMC public health 2012, 12, 950. [Google Scholar] [CrossRef]
- Jayarao, B.M.; Wang, L. A study on the prevalence of gram-negative bacteria in bulk tank milk. Journal of dairy science 1999, 82, 2620–2624. [Google Scholar] [CrossRef]
- Nobrega, D.B.; Calarga, A.P.; Nascimento, L.C.; Vasconcelos, C.G.C.; de Lima, E.M.; Langoni, H.; Brocchi, M. Molecular characterization of antimicrobial resistance in Klebsiella pneumoniae isolated from Brazilian dairy herds. Journal of dairy science 2021, 104, 7210–7224. [Google Scholar] [CrossRef]
- Njage, P.M.K.; Dolci, S.; Jans, C.; Wangoh, J.; Lacroix, C.; Meile, L. Ampicillin resistance and extended spectrum β-lactamases in Enterobacteriaceae isolated from raw and spontaneously fermented camel milk. African Journal of Microbiology Research 2012, 6, 1446–1452. [Google Scholar]
- Massa, S.; Gardini, F.; Sinigaglia, M.; Guerzoni, M.E. Klebsiella pneumoniae as a spoilage organism in mozzarella cheese. Journal of dairy science 1992, 75, 1411–1414. [Google Scholar] [CrossRef] [PubMed]
- Abushaala, F.; Alwoshesh, M. Bacteriological Evaluation of Fermanted Milk (Laban Raieb) in Misurata City, Libya. Journal of Science 2018, 792–802. [Google Scholar]
- Yao, K.; Zinzendorf, N.Y.; Bohoua, G.; Kouassi, K.A.; Koua, A.; Kouadio, L.K.; Kouamé, P.; Loukou, G.Y. Occurrence of Enterobacter sakazakii (Cronobacter) and Other Enterobacteriaceae in Commercial Powdered Infant Formula in Abidjan, Ivory Coast. Food and Nutrition Sciences 2012, 3, 822–826. [Google Scholar] [CrossRef]
- Sani, N.A.; Lim, Y.Y. Enterobacteriaceae, cronobacter(enterobacter) sakazakii and microbial population in infant formula products in the Malaysian market. Sains Malaysiana 2011, 40, 345–351. [Google Scholar]
- Oonaka, K.; Furuhata, K.; Hara, M.; Fukuyama, M. Powder infant formula milk contaminated with Enterobacter sakazakii. Japanese journal of infectious diseases 2010, 63, 103–107. [Google Scholar] [CrossRef] [PubMed]
- Estuningsih, S.; Kress, C.; Hassan, A.A.; Akineden, O.; Schneider, E.; Usleber, E. Enterobacteriaceae in dehydrated powdered infant formula manufactured in Indonesia and Malaysia. Journal of food protection 2006, 69, 3013–3017. [Google Scholar] [CrossRef]
- Zhou, X.; Gao, J.; Huang, Y.; Fu, S.; Chen, H. Antibiotic resistance pattern of Klebsiella pneumoniae and Enterobacter sakazakii isolates from powdered infant formula. African Journal Microbiology Research 2011, 5, 3073–3077. [Google Scholar]
- Muytjens, H.L.; Roelofs-Willemse, H.; Jaspar, G.H. Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae. Journal of clinical microbiology 1988, 26, 743–746. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.; Cao, B.; Gao, Q.; Sun, Y.; Liu, P.; Feng, L.; Wang, L. Detection of Enterobacter sakazakii and other pathogens associated with infant formula powder by use of a DNA microarray. Journal of clinical microbiology 2009, 47, 3178–3184. [Google Scholar] [CrossRef] [PubMed]
- Giammanco, G.M.; Aleo, A.; Guida, I.; Mammina, C. Molecular epidemiological survey of Citrobacter freundii misidentified as Cronobacter spp. (Enterobacter sakazakii) and Enterobacter hormaechei isolated from powdered infant milk formula. Foodborne pathogens and disease 2011, 8, 517–525. [Google Scholar] [CrossRef] [PubMed]
- Hayati, M.; Indrawati, A.; Mayasari, N.L.P.I.; Istiyaningsih, I.; Atikah, N. Molecular detection of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates of chicken origin from East Java, Indonesia. Veterinary world 2019, 12, 578. [Google Scholar] [CrossRef] [PubMed]
- Xu, T.; Wu, X.; Cao, H.; Pei, T.; Zhou, Y.; Yang, Y.; Yang, Z. The Characteristics of Multilocus Sequence Typing, Virulence Genes and Drug Resistance of Klebsiella pneumoniae Isolated from Cattle in Northern Jiangsu, China. Animals 2022, 12, 2627. [Google Scholar] [CrossRef] [PubMed]
- Fu, S.; Wen, C.; Wang, Z.; Qiu, Y.; Zhang, Y.; Zuo, J.; Xu, Y.; Han, X.; Luo, Z.; Chen, W. Molecular Epidemiology and Antimicrobial Resistance of Outbreaks of Klebsiella pneumoniae Clinical Mastitis in Chinese Dairy Farms. Microbiology Spectrum 2022, 10, e02997–02922. [Google Scholar] [CrossRef]
- Timofte, D.; Maciuca, I.E.; Evans, N.J.; Williams, H.; Wattret, A.; Fick, J.C.; Williams, N.J. Detection and molecular characterization of Escherichia coli CTX-M-15 and Klebsiella pneumoniae SHV-12 β-lactamases from bovine mastitis isolates in the United Kingdom. Antimicrobial agents and chemotherapy 2014, 58, 789–794. [Google Scholar] [CrossRef]
| No. | Blast NCBI 16S rDNA | Nucleotide Identity (%) | Type of samples |
|---|---|---|---|
| 1 | K. pneumoniae | 99 | Raw cow’s milk |
| 2 | K. pneumoniae | 99 | Raw cow’s milk |
| 3 | K. pneumoniae | 99 | Raw cow’s milk |
| 4 | K. pneumoniae | 99 | She-camel’s milk |
| 5 | K. pneumoniae | 98 | Raw fermented milk |
| 6 | K. pneumoniae | 99 | Ricotta cheese |
| 7 | K. pneumoniae | 99 | Maasora cheese |
| 8 | K. pneumoniae | 99 | Maasora cheese |
| 9 | K. pneumoniae | 99 | Maasora cheese |
| 10 | K. pneumoniae | 100 | Maasora cheese |
| 11 | K. pneumoniae | 99 | Imported soft cheese |
| 12 | K. pneumoniae | 100 | Full cream milk powder |
| 13 | K. pneumoniae | 99 | Full cream milk powder |
| 14 | K. pneumoniae | 100 | Infant formula |
| 15 | K. pneumoniae | 99 | Fortified milk powder |
| 16 | K. pneumoniae | 99 | Cereal baby food |
| No. | No. of Isolates | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amoxycillin (10µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 2 | Ampicillin (10µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 3 | Bacitracin (10µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 4 | Penicillin G (10µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 5 | Methicillin (5µg) | R | R | R | R | R | S | R | R | R | R | R | R |
| 6 | Erythromycin (15µg) | R | R | R | I | R | R | R | R | R | R | R | R |
| 7 | Kanamycin (30µg) | I | S | I | R | R | S | I | I | S | S | I | I |
| 8 | Lincomycin (10µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 9 | Tobramycin (10µg) | I | I | R | I | R | S | I | R | S | I | R | I |
| 10 | Levofloxacin (5µg) | S | S | S | S | S | S | S | S | S | S | S | S |
| 11 | Clindamycin (2µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 12 | Doxycycline (30µg) | S | R | S | S | S | S | S | S | S | R | S | S |
| 13 | Cloxacillin (5µg) | R | R | R | R | R | R | R | R | R | R | R | R |
| 14 | Nitrofurantoin (300µg) | S | S | S | S | I | S | R | I | I | I | I | R |
| 15 | Oxytetracyclin (30µg) | I | R | R | I | I | I | R | R | I | R | R | I |
| 16 | Streptomycin (10µg) | I | I | S | S | R | S | I | I | S | R | I | R |
| 17 | Tetracycline (30µg) | S | S | S | I | S | S | S | S | S | R | S | I |
| 18 | Chloramphenicol (30µg) | S | S | S | S | S | S | S | S | S | S | S | S |
| 19 | Sulphamethoxazole/ Trimethoprim (25µg) |
S | I | R | S | S | S | S | S | S | R | S | S |
| 20 | Amoxycillin/ Clavulanic acid (30µg) | S | I | S | I | S | S | S | S | S | I | S | S |
| 21 | Pipercillin/Tazlactm (100/10µg) | S | I | I | S | S | S | I | S | S | S | I | I |
| 22 | Cephoxitin (30µg) | I | R | I | I | S | I | R | I | S | R | I | R |
| 23 | Cefoperazone/ Sulbactin (75/30µg) | S | I | I | S | S | S | I | S | S | I | I | S |
| 24 | Cefotaxime (30µg) | S | R | R | I | S | S | I | S | I | R | S | I |
| 25 | Ceftriaxone (30µg) | S | I | I | S | S | S | I | S | S | S | S | I |
| 26 | Ceftazidim (30µg) | R | R | R | R | I | R | R | R | R | R | R | R |
| 27 | Aztreonam (30µg) | S | S | S | S | S | S | S | S | S | - | S | I |
| 28 | Imipenem (10µg) | S | R | R | S | S | S | S | S | S | S | S | S |
| 29 | Ertapenem (10µg) | S | S | S | S | S | S | S | S | S | S | S | S |
| 30 | Amikacin (30µg) | S | S | S | S | S | S | S | S | S | S | S | S |
| 31 | Gentamicin (10µg) | S | S | S | S | S | S | S | S | S | S | S | S |
| 32 | Ciprofloxacin (5µg) | S | S | S | S | S | S | S | R | S | S | S | S |
| IEH (10/750 µg) | - | MBL | MBL | - | - | - | - | - | - | - | - | - | |
| Sensitivity % | 51.5 | 27.2 | 36.3 | 45.4 | 51.5 | 63.6 | 36.3 | 45.4 | 57.5 | 30.3 | 42.4 | 33.3 | |
| Intermediate % | 15.1 | 21.2 | 15.1 | 21.2 | 9 | 6 | 21.2 | 12.1 | 9 | 12.1 | 18.1 | 24.2 | |
| Resistance % | 33.3 | 48.8 | 48.4 | 33.3 | 39.3 | 30.3 | 42.4 | 42.4 | 33.3 | 54.5 | 39.3 | 42.4 | |
| No | Name of Antibiotic | Resistance No. (%) | Intermediate No. (%) | Sensitive No. (%) |
|---|---|---|---|---|
| 1 | Amoxycillin (10µg) | 12 (100) | 0 (0) | 0 (0) |
| 2 | Ampicillin (10µg) | 12 (100) | 0 (0) | 0 (0) |
| 3 | Bacitracin (10µg) | 12 (100) | 0 (0) | 0 (0) |
| 4 | Penicillin G (10µg) | 12 (100) | 0 (0) | 0 (0) |
| 5 | Methicillin (5µg) | 11 (91.7) | 0 (0) | 1 (8.3) |
| 6 | Erythromycin (15µg) | 11 (91.7) | 1 (8.3) | 0 (0) |
| 7 | Kanamycin (30µg) | 2 (16.7) | 6 (50) | 4 (33.3) |
| 8 | Lincomycin (10µg) | 12 (100) | 0 (0) | 0 (0) |
| 9 | Tobramycin (10µg) | 4 (33.3) | 6 (50) | 2 (16.7) |
| 10 | Levofloxacin (5µg) | 0 (0) | 0 (0) | 12 (100) |
| 11 | Clindamycin (2µg) | 12 (100) | 0 (0) | 0 (0) |
| 12 | Doxycycline (30µg) | 2 (16.7) | 0 (0) | 10 (83.3) |
| 13 | Cloxacillin (5µg) | 12 (100) | 0 (0) | 0 (0) |
| 14 | Nitrofurantoin (300µg) | 2 (16.6) | 5 (41.7) | 5 (41.7) |
| 15 | Oxytetracyclin (30µg) | 6 (50) | 6 (50) | 0 (0) |
| 16 | Streptomycin (10µg) | 3 (25) | 5 (41.7) | 4 (33.3) |
| 17 | Tetracycline (30µg) | 1 (8.3) | 2 (16.7) | 9 (75) |
| 18 | Chloramphenicol (30µg) | 0 (0) | 0 (0) | 12 (100) |
| 19 | Sulphamethoxazole/ Trimethoprim (25µg) | 2 (16.7) | 1 (8.3) | 9 (75) |
| 20 | Amoxycillin/ Clavulanic acid (30µg) | 0 (0) | 3 (25) | 9 (75) |
| 21 | Pipercillin/ Tazlactm (100/10µg) | 0 (0) | 5 (41.6) | 7 (58.3) |
| 22 | Cephoxitin (30µg) | 4 (33.3) | 6 (50) | 2 (16.7) |
| 23 | Cefoperazone+ Sulbactin (75/30µg) | 0 (0) | 5/ (41.7) | 7 (58.3) |
| 24 | Cefotaxime (30µg) | 3 (25) | 4 (33.3) | 5 (41.7) |
| 25 | Ceftriaxone (30µg) | 0 (0) | 4 (33.3) | 8 (66.7) |
| 26 | Ceftazidim (30µg) | 11 (91.7) | 1 (8.3) | 0 (0) |
| 27 | Aztreonam (30µg) | 0 (0) | 1 (9.1) | 10 (90.9) |
| 28 | Imipenem (10µg) | 2 (16.7) | 0 (0) | 10 (83.3) |
| 29 | Ertapenem (10µg) | 0 (0) | 0 (0) | 12 (100) |
| 30 | Amikacin (30µg) | 0 (0) | 0 (0) | 12 (100) |
| 31 | Gentamicin (10µg) | 0 (0) | 0 (0) | 12 (100) |
| 32 | Ciprofloxacin (5µg) | 1 (8.3) | 0 (0) | 11 (91.7) |
| No | Name of Antibiotic | Resistance isolates | ARI | MDR |
|---|---|---|---|---|
| 1 | Amoxycillin (10µg) | 12/100 | 0.03 | 36.3 |
| 2 | Ampicillin (10µg) | 12/100 | 0.03 | 36.3 |
| 3 | Bacitracin (10µg) | 12/100 | 0.03 | 36.3 |
| 4 | Penicillin G (10µg) | 12/100 | 0.03 | 36.3 |
| 5 | Methicillin (5µg) | 11/91.6 | 0.02 | 33.3 |
| 6 | Erythromycin (15µg) | 11/91.6 | 0.02 | 33.3 |
| 7 | Kanamycin (30µg) | 2/16.6 | 0.005 | 6 |
| 8 | Lincomycin (10µg) | 12/100 | 0.03 | 36.3 |
| 9 | Tobramycin (10µg) | 4/33.3 | 0.01 | 12.1 |
| 10 | Levofloxacin (5µg) | 0/0 | 0 | 0 |
| 11 | Clindamycin (2µg) | 12/100 | 0.03 | 36.3 |
| 12 | Doxycycline (30µg) | 2/16.6 | 0.005 | 6 |
| 13 | Cloxacillin (5µg) | 12/100 | 0.03 | 36.3 |
| 14 | Nitrofurantoin (300µg) | 2/16.6 | 0.005 | 6 |
| 15 | Oxytetracyclin (30µg) | 6/50 | 0.01 | 18.1 |
| 16 | Streptomycin (10µg) | 3/25 | 0.007 | 9 |
| 17 | Tetracycline (30µg) | 1/8.3 | 0.002 | 3 |
| 18 | Chloramphenicol (30µg) | 0/0 | 0 | 0 |
| 19 | Sulphamethoxazole/ Trimethoprim (25µg) | 2/16.6 | 0.005 | 6 |
| 20 | Amoxycillin/ Clavulanic acid (30µg) | 0/0 | 0 | 0 |
| 21 | Pipercillin/ Tazlactm (100/10µg) | 0/0 | 0 | 0 |
| 22 | Cephoxitin (30µg) | 4/33.3 | 0.01 | 12.1 |
| 23 | Cefoperazone+ Sulbactin (75/30µg) | 0/0 | 0 | 0 |
| 24 | Cefotaxime (30µg) | 3/25 | 0.007 | 9 |
| 25 | Ceftriaxone (30µg) | 0/0 | 0 | 0 |
| 26 | Ceftazidim (30µg) | 11/91.6 | 0.02 | 33.3 |
| 27 | Aztreonam (30µg) | 0/0 | 0 | 0 |
| 28 | Imipenem (10µg) | 2/16.6 | 0.005 | 6 |
| 29 | Ertapenem (10µg) | 0/0 | 0 | 0 |
| 30 | Amikacin (30µg) | 0/0 | 0 | 0 |
| 31 | Gentamicin (10µg) | 0/0 | 0 | 0 |
| 32 | Ciprofloxacin (5µg) | 1/8.3 | 0.002 | 3 |
| No. of Isolates | No. of Resistant Antibiotics (Total) | MARI |
|---|---|---|
| 1 | 11 (32) | 0.33 |
| 2 | 16 (32) | 0.48 |
| 3 | 16 (32) | 0.48 |
| 4 | 11 (32) | 0.33 |
| 5 | 13 (32) | 0.39 |
| 6 | 10 (32) | 0.3 |
| 7 | 14 (32) | 0.42 |
| 8 | 14 (32) | 0.42 |
| 9 | 11 (32) | 0.33 |
| 10 | 18 (32) | 0.54 |
| 11 | 13 (32) | 0.39 |
| 12 | 14 (32) | 0.42 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
